Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Dec 19.

Published in final edited form as: Pediatr Neurol. 2015 Apr 9;53(1):31–46. doi: 10.1016/j.pediatrneurol.2015.03.019

Table 9.

Event-Free and Overall Survival Rates Among Medulloblastoma Patients

			5-year EFS			5-year OS

		# Patients	%	SE	P value	%	SE	P value
All		36	60.0	8.3		68.3	7.9
M-Stage	M0	26	72.0	9.0	.007	76.0	8.5	.074
	M1+	10	30.0	14.5	.007	50.5	15.8	.074
Resection	GTR/No Residual	20	63.2	11.1	.169	68.4	10.7	345
	<GTR or Residual	13	46.2	13.8	.169	61.5	13.5	345
	Unknown	3
Histology	Desmoplastic	14	78.6	11.0	.038	85.7	9.4	.046
	Non-Desmoplastic	18	50.5	11.8	.038	60.6	11.6	.046
	Unable to Determine	4
Desmoplasia -M-Stage	Desmoplastic M0	13	84.6	10.0	.091
	Non-Desmoplastic M0	10	60.0	15.5	.091
	Desmoplastic M1+	1	0		.014
	Non-Desmoplastic M1+	8	37.5	17.1	.014
	Unable to Determine	4